These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38598026)

  • 1. Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States.
    Erguera XA; Koester KA; Diaz Tsuzuki M; Dance KV; Flores R; Kerman J; McNulty MC; Colasanti JA; Collins LF; Montgomery ET; Johnson MO; Sauceda JA; Christopoulos KA
    AIDS Behav; 2024 Jul; 28(7):2226-2238. PubMed ID: 38598026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida.
    Fisk-Hoffman RJ; Ranger SS; Gracy A; Gracy H; Manavalan P; Widmeyer M; Leeman RF; Cook RL; Canidate S
    AIDS Patient Care STDS; 2024 Jun; 38(6):275-285. PubMed ID: 38686517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
    Philbin MM; Parish CL; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):263-270. PubMed ID: 32530905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use.
    Philbin MM; Parish C; Bergen S; Kerrigan D; Kinnard EN; Reed SE; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Alcaide ML; Metsch LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):23-30. PubMed ID: 33400587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites.
    Fletcher L; Burrowes S; Sabin LL; McCann N; Khan GK; Ruiz-Mercado G; Johnson S; Kimmel SD; Pierre C; Drainoni ML
    AIDS Patient Care STDS; 2024 May; 38(5):221-229. PubMed ID: 38656905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I Feel Like I Don't Even Have HIV Anymore"-Facilitators, Barriers, and Experience regarding Use of Long-Acting Injectable Antiretroviral Therapy Among Persons with HIV in North Carolina.
    Agarwal H; Huffstetler HE; Lopez C; Go VF; Napravnik S; Farel CE; Rutstein SE
    AIDS Patient Care STDS; 2024 Jul; 38(7):324-329. PubMed ID: 38860413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.
    Simoni JM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Tapia K; Graham SM; Ho R; Collier AC
    AIDS Patient Care STDS; 2019 Mar; 33(3):104-111. PubMed ID: 30844308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda.
    Kennedy CE; Zhao T; Vo AV; Nakubulwa R; Nabakka P; Jackson J; Rosen JG; Chang LW; Reynolds SJ; Quinn TC; Nakigozi G; Kigozi G; Kagaayi J; Nalugoda F; Ddaaki WG; Grabowski MK; Nakyanjo N
    AIDS Patient Care STDS; 2023 Jun; 37(6):316-322. PubMed ID: 37294280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI UP Project.
    Nguyen N; Lane B; Golub SA; Chastain C; Zucker J; King K; Terry M; Burdge J; Carnevale C; Muscarella A; Castor D; Kutner B; Meyers K
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26282. PubMed ID: 38965977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.
    Jolayemi O; Bogart LM; Storholm ED; Goodman-Meza D; Rosenberg-Carlson E; Cohen R; Kao U; Shoptaw S; Landovitz RJ
    PLoS One; 2022; 17(2):e0262926. PubMed ID: 35113892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.
    Moreno C; Izquierdo R; Alejos B; Hernando V; Pérez de la Cámara S; Peraire J; Macías J; Bernal E; Albendín-Iglesias H; Alcaraz B; Suárez-García I; Moreno S; Jarrín I;
    AIDS Patient Care STDS; 2024 Jul; 38(7):305-314. PubMed ID: 38916077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South.
    Collins LF; Corbin-Johnson D; Asrat M; Morton ZP; Dance K; Condra A; Jenkins K; Todd-Turner M; Sumitani J; Smith BL; Armstrong WS; Colasanti JA
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac455. PubMed ID: 36147599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic.
    Christopoulos KA; Grochowski J; Mayorga-Munoz F; Hickey MD; Imbert E; Szumowski JD; Dilworth S; Oskarsson J; Shiels M; Havlir D; Gandhi M
    Clin Infect Dis; 2023 Feb; 76(3):e645-e651. PubMed ID: 35913500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South.
    Campbell CK; Kielhold K; Reynolds HE; Vincent W; Siconolfi DE; Ramos SD; Ogunbajo A; Kegeles SM; Storholm ED
    Int J Environ Res Public Health; 2024 May; 21(5):. PubMed ID: 38791816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya.
    Simoni JM; Beima-Sofie K; Wanje G; Mohamed ZH; Tapia K; McClelland RS; Ho RJY; Collier AC; Graham SM
    J Int Assoc Provid AIDS Care; 2021; 20():23259582211000517. PubMed ID: 33685272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.
    Biello KB; Edeza A; Salhaney P; Biancarelli DL; Mimiaga MJ; Drainoni ML; Childs ES; Bazzi AR
    AIDS Care; 2019 Oct; 31(10):1214-1220. PubMed ID: 30822103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States.
    McCrimmon T; Collins LF; Perez-Brumer A; Bazzi AR; Shaffer VA; Kerrigan D; Alcaide ML; Philbin MM
    AIDS Patient Care STDS; 2024 Feb; 38(2):61-69. PubMed ID: 38381949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most.
    Philbin MM; Bergen S; Parish C; Kerrigan D; Kinnard EN; Reed S; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Vaughn M; Gutierrez JI; Fischl MA; Alcaide M; Metsch LR
    AIDS Behav; 2022 Apr; 26(4):1260-1269. PubMed ID: 34648131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics.
    Collins LF; Koester KA; McNulty MC; Montgomery ET; Johnson MO; Neilands TB; Dilworth SE; Sauceda JA; Dance K; Erguera X; Diaz Tsuzuki M; Gutierrez JI; Christopoulos KA; Colasanti JA
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae265. PubMed ID: 38854389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York.
    Irvine MK; Zimba R; Avoundjian T; Peterson M; Emmert C; Kulkarni SG; Philbin MM; Kelvin EA; Nash D
    JMIR Res Protoc; 2024 Mar; 13():e56892. PubMed ID: 38536227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.